Novartis takes aim at risky Parkinson’s target with $1.5bn UCB dealNovartis has licensed a potential drug for Parkinson’s from Belgium’s UCB that it thinks could be the first Share XNovartis takes aim at risky Parkinson’s target with $1.5bn UCB dealhttps://pharmaphorum.com/news/novartis-takes-aim-at-risky-parkinsons-target-with-1-5bn-ucb-deal/
UK government rubberstamps millions of extra COVID vaccinesThe UK government has placed a 114 million-dose order with Pfizer/BioNTech and Moderna – sufficient to provide two doses Share XUK government rubberstamps millions of extra COVID vaccineshttps://pharmaphorum.com/news/uk-government-rubberstamps-millions-of-extra-covid-vaccines/
GSK pumps £30m into a new Oxford University partnershipGlaxoSmithKline has formed a five-year partnership with Oxford University to set up a new institute that will apply Share XGSK pumps £30m into a new Oxford University partnershiphttps://pharmaphorum.com/news/gsk-pumps-30m-into-a-new-oxford-university-institute/
Digital health: the new normal?Personalised and tailored healthcare that utilises patient’s data is rapidly becoming a reality. Ben Hargreaves looks at the Share XDigital health: the new normal?https://pharmaphorum.com/digital/digital-health-the-new-normal/
The booming life sciences sector needs dynamic real estate supportBruntwood SciTech is the UK’s leading property provider dedicated to driving the growth of the science and technology Share XThe booming life sciences sector needs dynamic real estate supporthttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/the-booming-life-sciences-sector-needs-dynamic-real-estate-support/
How biomarkers and bioanalytics are changing R&DBiomarkers have been causing a paradigm shift in how HCPs treat patients for some time – now they Share XHow biomarkers and bioanalytics are changing R&Dhttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/nexelis-biomarkers-bioanalytics-changing-rd/
Recruiting patients to increase diversity & inclusion in clinical trials: one size does not fit allMore so now than ever, the inclusion of more diverse, and often more relevant, study populations is gathering Share XRecruiting patients to increase diversity & inclusion in clinical trials: one size does not fit allhttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/recruiting-patients-to-increase-diversity-inclusion-in-clinical-trials-one-size-does-not-fit-all/
The booming life sciences sector needs dynamic real estate supportBruntwood SciTech is the UK’s leading property provider dedicated to driving the growth of the science and technology Share XThe booming life sciences sector needs dynamic real estate supporthttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/the-booming-life-sciences-sector-needs-dynamic-real-estate-support/
How biomarkers and bioanalytics are changing R&DBiomarkers have been causing a paradigm shift in how HCPs treat patients for some time – now they Share XHow biomarkers and bioanalytics are changing R&Dhttps://deep-dive.pharmaphorum.com/magazine/patients-partnerships/nexelis-biomarkers-bioanalytics-changing-rd/
Oncology treatment decisions aren’t just based on clinical data Share XOncology treatment decisions aren’t just based on clinical datahttps://pharmaphorum.com/webinars/oncology-treatment-decisions-arent-just-based-on-clinical-data/
The power of R&D collaborations to improve outcomes in rare diseases Share XThe power of R&D collaborations to improve outcomes in rare diseaseshttps://pharmaphorum.com/webinars/pharma-research-outcomes-rare-diseases/
Using AI to make a big impact for emerging and mid-sized biopharma companies Share XUsing AI to make a big impact for emerging and mid-sized biopharma companieshttps://pharmaphorum.com/webinars/using-ai-to-make-a-big-impact-for-emerging-and-mid-sized-biopharma-companies/
Sales coaching: preparing for the new reality in pharmaCOVID-19 has been a catalyst for a huge amount of change across the pharmaceutical industry, acting as an Share XSales coaching: preparing for the new reality in pharmahttps://pharmaphorum.com/whitepapers/pharma-sales-coaching-new-reality/
Utilising content metrics to improve digital engagementPharma companies are producing and distributing more digital content than ever due to the pandemic, meaning the content Share XUtilising content metrics to improve digital engagementhttps://pharmaphorum.com/whitepapers/content-metrics-digital-engagement-veeva/
Transform patient experience with intelligent hyper-personalisationSince 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and Share XTransform patient experience with intelligent hyper-personalisationhttps://pharmaphorum.com/whitepapers/patient-experience-personalisation-indegene/
Health Innovators: Senseonics’ Francine Kaufman Share XHealth Innovators: Senseonics’ Francine Kaufmanhttps://pharmaphorum.com/digital/health-innovators-senseonics-francine-kaufman/
Novo Nordisk on seeking partnerships to expand its portfolio Share XNovo Nordisk on seeking partnerships to expand its portfoliohttps://pharmaphorum.com/r-d/novo-nordisk-seeking-partnerships-diabetes/
Real-world evidence and qualitative research: the ELICIT podcast Share XReal-world evidence and qualitative research: the ELICIT podcasthttps://pharmaphorum.com/podcast/real-world-evidence-and-qualitative-research
Social Health: What it is and why it matters for pharma Share XSocial Health: What it is and why it matters for pharmahttps://pharmaphorum.com/partner-content/social-health-what-it-is-and-why-it-matters-for-pharma/
How Label Management Solutions Can Help CDMOS Grow Their In-House Capabilities Share XHow Label Management Solutions Can Help CDMOS Grow Their In-House Capabilitieshttps://pharmaphorum.com/partner-content/how-label-management-solutions-can-help-cdmos-grow-their-in-house-capabilities/
Poor Glycaemic Control and Tooth Loss Study Share XPoor Glycaemic Control and Tooth Loss Studyhttps://pharmaphorum.com/partner-content/largest-tooth-loss-research-study-results/
Fishawack Health welcomes expert-led dermatology initiative FIDE to its group Share XFishawack Health welcomes expert-led dermatology initiative FIDE to its grouphttps://pharmaphorum.com/partner-content/fishawack-health-welcomes-expert-led-dermatology-initiative-fide-to-its-group/
AXON appoints Colette Balaam as its new US Managing Partner Share XAXON appoints Colette Balaam as its new US Managing Partnerhttps://pharmaphorum.com/partner-content/axon-appoints-colette-balaam-as-its-new-us-managing-partner/
Prescient Healthcare Group to Partner with Bridgepoint Development Capital Share XPrescient Healthcare Group to Partner with Bridgepoint Development Capitalhttps://pharmaphorum.com/partner-content/prescient-healthcare-group-to-partner-with-bridgepoint-development-capital/
